文献速递疼痛医学

慢性尾骨痛奇神经节阻滞治疗成功的预测因素

Predictive factors affecting treatment success in ganglion impar block applied in chronic coccygodynia.
PubMed 文献 · Reg Anesth Pain Med · 2022-06-23

该回顾性研究纳入102例接受奇神经节阻滞的慢性尾骨痛患者,治疗后第3个月疼痛数字评分下降≥50%定义为治疗成功。治疗成功率为69.6%(95%CI 60.4%至78.7%)。多变量回归显示,症状持续时间超过24.5个月和存在永久性半脱位与治疗成功可能性降低相关。

要点

  • 奇神经节阻滞治疗慢性尾骨痛成功率较高,达69.6%。
  • 症状持续时间超过24.5个月与治疗成功可能性降低独立相关。
  • 存在尾骨永久性半脱位也与治疗成功可能性降低独立相关。

核心结论

  • 奇神经节阻滞治疗慢性尾骨痛的成功率较高,但术前症状持续时间较长和存在永久性半脱位与治疗成功可能性降低相关。

研究设计与样本

  • 回顾性研究,筛查2018年1月1日至2021年1月1日期间接受奇神经节阻滞治疗尾骨痛的患者,195例中102例符合最终分析标准并纳入研究。

主要发现

  • 治疗成功率为69.6%(95%CI 60.4%至78.7%),成功标准为治疗后第3个月数字评定量表疼痛评分下降≥50%。
  • 通过受试者工作特征分析确定尾骨痛症状持续时间的显著截断值为24.5个月,超过该值定义为症状持续时间延长。
  • 多变量逻辑回归最终模型中,存在永久性半脱位(是 vs 否)与治疗成功显著相关(OR 9.56,95%CI 1.44至63.40,p=0.02)。
  • 症状持续时间延长(是 vs 否)与治疗成功显著相关(OR 137.00,95%CI 19.59至958.03,p<0.001)。

临床怎么用

  • 对于慢性尾骨痛患者,奇神经节阻滞可作为治疗选择,但术前症状持续时间较长或存在尾骨永久性半脱位者治疗成功可能性较低,需综合评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aimed to determine the predictive factors affecting the success of ganglion impar block applied in chronic coccygodynia. METHODS: Patients who received ganglion impar block to treat coccygodynia between January 1, 2018 and January 1, 2021 were retrospectively screened. Of the 195 patients, 102 met the final analysis criteria and were included in the study. Demographic data, coccygodynia etiology, coccygodynia symptom duration, history of coccyx fracture, regular opioid use, and presence of other musculoskeletal chronic pain conditions accompanying coccygodynia were obtained from patient records. In addition, coccyx radiography was examined, and coccyx curvature type, permanent subluxation, and posterior spicule presence were evaluated. The criterion for treatment success was set as ≥50% reduction in Numerical Rating Scale pain scores in the third month after treatment. RESULTS: Treatment was successful of the patients in 69.6% (95% CI 60.4% to 78.7%). A significant cut-off value (24.5 months) was determined for coccygodynia symptom duration using receiver operating characteristic analysis. Symptom duration above the cut-off value was defined as prolonged symptom duration. Multivariable logistic regression analysis was performed to determine the predictive factors affecting treatment success in the third month after injection. In the final model, the presence of permanent subluxation (yes vs no), and the prolonged symptom duration (yes vs no) were found to have significant effects on treatment success (OR 9.56, 95% CI 1.44 to 63.40, p=0.02; OR 137.00, 95% CI 19.59 to 958.03, p<0.001). CONCLUSION: Treatment success of ganglion impar block for coccygodynia is high. However, longer preprocedure symptom duration and the presence of permanent subluxation were associated with a decrease likelihood of treatment success.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Celenlioglu AE, Sir E. Predictive factors affecting treatment success in ganglion impar block applied in chronic coccygodynia. Reg Anesth Pain Med. 2022. PMID: 35738667. doi:10.1136/rapm-2022-103582

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。